Corporate Development Team
Barbara Deptula
Executive Vice President and Chief Corporate Development Officer
Renee Cohen
Vice President, Corporate Strategy
Specialty Pharma
David Colpman
Senior Vice President, Business Development
Pierre Gosselin
Senior Director, Business Development
David Chapman
Senior Director Scientific Licensing, Business Development
Armand Girard
Senior Director Scientific Licensing, Business Development
Marty Steiner
Senior Director Scientific Licensing, Business Development
Charlie Alexander
Director, Business Development
Cherise Kent
Director, Business Development
Björn Peters
Director, Business Development (Shire-Movetis)
HGT
Deanna Petersen
Vice President, Business Development
Gary Clements
Senior Director, Business Development
Jennifer King
Senior Director Scientific Licensing, Business Development
Greg Robinson
Senior Director Scientific Licensing, Business Development
Ashley Lawton
Director, Business Development
Strategic Investment Group (SIG)
Gwen Melincoff
Senior Vice President, Business Development
Brian Piper
Senior Director, Business Development
For export or distribution enquiries relating to Europe, Middle East, Africa, Latin America, please contact: ttustin@shire.com
For export and distribution enquiries relating to Pacific Rim including India, Pakistan, Australia and New Zealand, please contact: tooi@shire.com
Key fact
We try to find new therapies
for rare and life-threatening
diseases.
